# US 2021/0275568 A1 · Dietary fibre composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275568 A1
- Document ID: US20210275568A1
- Status: Published application
- Kind: A1
- Application number: 16/484,002
- Filed: 2015-07-06
- Published: 2021-09-09
- Earliest claimed: 2014-07-04
- Assignees: Koye Pharmaceuticals Private Limited
- Applicants: Koye Pharmaceuticals Private Limited
- Inventors: Ajay Nilawar
- Web page: https://patentgrep.com/patent/US20210275568A1

## CPC

- A61K 9/14: Particulate form, e.g. powders, {Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles (microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51)}
- A61K 31/718: Starch or degraded starch, e.g. amylose, amylopectin
- A23L 29/219: Chemically modified starch; Reaction or complexation products of starch with other chemicals
- A23L 29/238: from seeds, e.g. locust bean gum or guar gum (starch A23L29/212; pectin A23L29/231)
- A23L 33/21: Addition of substantially indigestible substances, e.g. dietary fibres
- A23L 33/30: {Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence)}
- A61K 31/716: Glucans
- A61K 31/721: Dextrans
- A61K 31/736: Glucomannans or galactomannans, e.g. locust bean gum, guar gum
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/10: Laxatives
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/06: Antihyperlipidemics
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A water soluble dietary fibre composition and use thereof is disclosed. The composition comprises: (a) partially hydrolysed and re-polymerized starch, and (b) partially hydrolysed Guar gum.

## Claims

### Claim 1

A water soluble dietary fibre composition comprising: (a) partially hydrolysed and re-polymerized starch, and (b) partially hydrolysed Guar gum.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein said starch is Dextrin obtained from wheat or maize.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein said partially hydrolysed and re-polymerized starch is present in an amount of about 10 to 90% by weight of the composition.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein said partially hydrolysed Guar gum is present in an amount of about 5 to 40% by weight of the composition.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the composition comprises: (a) the partially hydrolysed and re-polymerized starch in an amount of about 80% by weight of the composition, and (b) the partially hydrolysed Guar gum in an amount of about 20% by weight of the composition.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein the composition has a bulk density between 0.2 to 0.6 mg/ml.

### Claim 7 (depends on 1)

The composition according to claim 1, wherein the composition has an untapped bulk density between 0.20 to 0.50 mg/ml.

### Claim 8 (depends on 1)

The composition according to claim 1, wherein the composition has a tapped bulk density between 0.20 to 0.50 mg/ml.

### Claim 9 (depends on 1)

The composition according to claim 1, further comprising one or more active or inactive ingredients.

### Claim 10 (depends on 1)

The composition according to claim 1, wherein the composition is formulated in the form of a liquid, powder, granules, tablets, pills, capsules, chewable tablets, or gummies.

### Claim 11 (depends on 1)

A method of using the composition according to claim 1 to treat one or more health conditions.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the health conditions comprise one or more health conditions selected from: diabetes, weight, cholesterol, blood glucose levels, blood lipid levels, acidity, constipation, mineral absorption, and bowel movement.

### Claim 13 (depends on 11)

The method according to claim 11, comprising administering the composition in an amount of about 0.1 to 50 gram per day.

### Claim 14 (depends on 9)

The composition according to claim 9, wherein the one or more active ingredients comprise: one or more minerals, one or more vitamins, one or more amino acids, one or more fatty acids, and/or one or more proteins.

### Claim 15 (depends on 9)

The composition according to claim 9, wherein the one or more inactive ingredients comprise: one or more fillers, one or more binders, one or more glidants, one or more lubricants, one or more stabilizers, one or more solubilizers, one or more disintegrants, one or more polymers, one or more sweeteners, and/or one or more flavoring agents.
